ES8600764A1 - Un procedimiento para la preparacion de derivados de espiro-hidantoina - Google Patents

Un procedimiento para la preparacion de derivados de espiro-hidantoina

Info

Publication number
ES8600764A1
ES8600764A1 ES532736A ES532736A ES8600764A1 ES 8600764 A1 ES8600764 A1 ES 8600764A1 ES 532736 A ES532736 A ES 532736A ES 532736 A ES532736 A ES 532736A ES 8600764 A1 ES8600764 A1 ES 8600764A1
Authority
ES
Spain
Prior art keywords
fch
formulas
reaction
chfn
nfch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532736A
Other languages
English (en)
Spanish (es)
Other versions
ES532736A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES8600764A1 publication Critical patent/ES8600764A1/es
Publication of ES532736A0 publication Critical patent/ES532736A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
ES532736A 1983-05-25 1984-05-23 Un procedimiento para la preparacion de derivados de espiro-hidantoina Granted ES532736A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
ES8600764A1 true ES8600764A1 (es) 1985-10-16
ES532736A0 ES532736A0 (es) 1985-10-16

Family

ID=23979057

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532736A Granted ES532736A0 (es) 1983-05-25 1984-05-23 Un procedimiento para la preparacion de derivados de espiro-hidantoina
ES540858A Expired ES8607304A1 (es) 1983-05-25 1985-03-01 Un procedimiento para la preparacion de derivados de espiro-hidantoina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES540858A Expired ES8607304A1 (es) 1983-05-25 1985-03-01 Un procedimiento para la preparacion de derivados de espiro-hidantoina

Country Status (19)

Country Link
US (1) US4464380A (OSRAM)
EP (1) EP0127412B1 (OSRAM)
JP (1) JPS604183A (OSRAM)
KR (1) KR860001869B1 (OSRAM)
AT (1) ATE57531T1 (OSRAM)
AU (1) AU543916B2 (OSRAM)
CA (1) CA1266270A (OSRAM)
DE (1) DE3483402D1 (OSRAM)
DK (1) DK163924C (OSRAM)
ES (2) ES532736A0 (OSRAM)
FI (1) FI78699C (OSRAM)
GR (1) GR82020B (OSRAM)
HU (1) HU190548B (OSRAM)
IE (1) IE57520B1 (OSRAM)
IL (1) IL71904A (OSRAM)
PH (1) PH21151A (OSRAM)
PL (3) PL143290B1 (OSRAM)
PT (1) PT78625A (OSRAM)
YU (2) YU43931B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
DK0769497T3 (da) * 1995-10-18 2003-04-07 Hoffmann La Roche Hydroxymethylering af tocopheroler
DK1144411T3 (da) 1998-12-19 2005-09-19 Janssen Pharmaceutica Nv Antihistaminspiroforbindelser
US20090076049A1 (en) * 2006-02-07 2009-03-19 Astrazeneca Ab Novel Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
IE50332B1 (en) * 1979-11-13 1986-04-02 Ici Ltd 1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
AU2856384A (en) 1984-11-29
IE841294L (en) 1984-11-25
CA1266270A (en) 1990-02-27
JPS604183A (ja) 1985-01-10
DE3483402D1 (de) 1990-11-22
ES8607304A1 (es) 1986-06-01
FI78699B (fi) 1989-05-31
FI78699C (fi) 1989-09-11
GR82020B (OSRAM) 1984-12-12
EP0127412A2 (en) 1984-12-05
YU212286A (en) 1987-10-31
YU43931B (en) 1989-12-31
ES540858A0 (es) 1986-06-01
DK163924B (da) 1992-04-21
DK250084D0 (da) 1984-05-22
IL71904A (en) 1988-01-31
PL143290B1 (en) 1988-02-29
DK250084A (da) 1984-11-26
KR860001869B1 (ko) 1986-10-24
HUT34194A (en) 1985-02-28
KR840009101A (ko) 1984-12-24
JPH0573754B2 (OSRAM) 1993-10-15
ES532736A0 (es) 1985-10-16
EP0127412A3 (en) 1987-09-02
FI842079A0 (fi) 1984-05-24
YU89784A (en) 1987-04-30
DK163924C (da) 1992-09-14
AU543916B2 (en) 1985-05-09
PL247804A1 (en) 1985-08-13
IL71904A0 (en) 1984-09-30
PH21151A (en) 1987-07-30
YU43958B (en) 1989-12-31
FI842079A7 (fi) 1984-11-26
US4464380A (en) 1984-08-07
EP0127412B1 (en) 1990-10-17
HU190548B (en) 1986-09-29
PT78625A (en) 1984-06-01
PL143070B1 (en) 1988-01-30
ATE57531T1 (de) 1990-11-15
PL252850A1 (en) 1985-11-19
IE57520B1 (en) 1993-05-19

Similar Documents

Publication Publication Date Title
ES474592A1 (es) Procedimiento para la preparacion de derivados de imidazoli-nina
ES8800132A1 (es) Un procedimiento para la produccion de compuestos de fenetanolamina
ES8703846A1 (es) Un procedimiento para preparar derivados de dihidropiridazi-nona
ES8306156A1 (es) Un procedimiento para la produccion de nuevas cefalosporinas.
ES8300785A1 (es) Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios
ES2044013T3 (es) Compuesto mesomorfico, una composicion de cristal liquido que contiene el compuesto y un dispositivo de cristal liquido que utiliza la composicion.
ES8504230A1 (es) Un metodo de producir un colorante de azul de formazan metalico reactivo
DK139494B (da) Kassette, særlig til montering af vægskilte.
ES8600764A1 (es) Un procedimiento para la preparacion de derivados de espiro-hidantoina
ES8707239A1 (es) Procedimiento para preparar nuevos derivados imidazo.
ES8404671A1 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES8202560A1 (es) Un procedimiento para la preparacion de una 3-yodometil-ce- falosporina
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8506707A1 (es) Un derivado de acido tiazolilacetico
IT8119387A0 (it) Circuito a sorgente di corrente costante, stabilizzato nei confronti della tensione e della temperatura.
IT1114442B (it) Circuito per sincronizzare il segnale alternato di un oscillatore,comandato ad impulsi,con un segnale alternato di riffrimento
JPS5355053A (en) Photoelectric encoder
SE8102285L (sv) Sprengemneskomposition
JPS5234739A (en) Light printer
ATE61201T1 (de) Fungizide alpha-azolylglykole.
ES8403465A1 (es) Un procedimiento para preparar derivados de pirimidona.
AR240788A2 (es) Una composicion promotora del crecimiento de vegetales.
ES2154640T3 (es) Procedimiento para la obtencion de 5-alquilpiridinas 2-substituidas.
ES8607925A1 (es) Un procedimiento para la preparacion del isomero r (dextrogiro)
ES8303403A1 (es) Procedimiento para la obtencion del 1-(2,3-dihidro-1,4-ben- zodioxin-2s-il)-5-(2,3-dihidro-1,4-benzodioxin-2r-il)-3-aza-pentan-1r-5s-diol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303